MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ImageneBio, Inc. - Common Stock (NQ:IMA)

5.940 +0.010 (+0.17%)
Streaming Delayed Price Updated: 9:30 AM EDT, Jul 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 493
Open 5.940
Bid (Size) 5.560 (400)
Ask (Size) 5.890 (100)
Prev. Close 5.930
Today's Range 5.940 - 5.940
52wk Range 3.940 - 8.950
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
ImageneBio Appoints Matt Robbins as General Counsel
Brings more than 15 years of corporate, securities, and transactional experience advising public and private life sciences companies 
From ImageneBio, Inc.
Via GlobeNewswire
These stocks are gapping in today's session ↗
Via Chartmill

Performance

YTD
-12.1%
-12.1%
1 Month
+5.5%
+5.5%
3 Month
+30.0%
+30.0%
6 Month
-12.3%
-12.3%
1 Year
-31.2%
-31.2%

More News

Read More
News headline image
ImageneBio to Participate in 2026 Jefferies Global Healthcare Conference in New York
From ImageneBio, Inc.
Via GlobeNewswire
News headline image
ImageneBio Reports First Quarter 2026 Financial Results and Provides IMG-007 Program Update
From ImageneBio, Inc.
Via GlobeNewswire
News headline image
ENDRA Life Sciences (NASDAQ: NDRA) Targets Billions With TAEUS® Liver Imaging Technology
Via AB Newswire
News headline image
ImageneBio Announces $30 Million Private Placement
From ImageneBio, Inc.
Via GlobeNewswire
News headline image
ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From ImageneBio, Inc.
Via GlobeNewswire
News headline image
ImageneBio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Company Update
From ImageneBio, Inc.
Via GlobeNewswire
News headline image
ImageneBio to Participate in Leerink Global Healthcare Conference
From ImageneBio, Inc.
Via GlobeNewswire
News headline image
ImageneBio Appoints Immunology Drug Development Veteran Dr. Ben Porter-Brown as Chief Medical Officer
From ImageneBio, Inc.
Via GlobeNewswire
News headline image
ImageneBio Reports Third Quarter 2025 Financial Results and Provides IMG-007 Program Update Following Closing of Reverse Merger, Concurrent Financing, and Strengthening of Management Team
From ImageneBio, Inc.
Via GlobeNewswire
News headline image
ImageneBio to Participate in Fourth Quarter 2025 Investor Conferences
From ImageneBio, Inc.
Via GlobeNewswire
News headline image
This Albemarle Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday ↗
Via Benzinga

Frequently Asked Questions

Is ImageneBio, Inc. - Common Stock publicly traded?
Yes, ImageneBio, Inc. - Common Stock is publicly traded.
What exchange does ImageneBio, Inc. - Common Stock trade on?
ImageneBio, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for ImageneBio, Inc. - Common Stock?
The ticker symbol for ImageneBio, Inc. - Common Stock is IMA on the Nasdaq Stock Market
What is the current price of ImageneBio, Inc. - Common Stock?
The current price of ImageneBio, Inc. - Common Stock is 5.940
When was ImageneBio, Inc. - Common Stock last traded?
The last trade of ImageneBio, Inc. - Common Stock was at 07/09/26 09:30 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story